Patent
Glutamate transporter activators and methods using same
22 Dec 2022
Abstract
The present invention provides compounds useful for treating, ameliorating or preventing a disease or disorder that is caused, induced or characterized by abnormal reduction in glutamate transporter activity or abnormal increase in extracellular CNS glutamate concentration in a subject. In certain embodiments, the compound stimulates a glutamate transporter.
Metrics
1 Record Views
Details
- Title
- Glutamate transporter activators and methods using same
- Creators
- Joseph M SalvinoAndreia C. K MortensenOle V Mortensen - Drexel University, Pharmacology and PhysiologySandhya Kortagere - Drexel University, Microbiology and Immunology
- Resource Type
- Patent
- Language
- English
- Patent
- US20220402938A1; A1
- Academic Unit
- Pharmacology and Physiology; Microbiology and Immunology
- Identifiers
- 991021904614104721